FENNEC PHARMACEUTICALS INC. Quarterly Return On Equity in % from Q4 2011 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Fennec Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from Q4 2011 to Q2 2024.
  • Fennec Pharmaceuticals Inc. Return On Equity for the quarter ending June 30, 2024 was -2.85K %, a 553% decline year-over-year.
  • Fennec Pharmaceuticals Inc. annual Return On Equity for 2023 was 336 %.
  • Fennec Pharmaceuticals Inc. annual Return On Equity for 2022 was -445 %, a 426% decline from 2021.
  • Fennec Pharmaceuticals Inc. annual Return On Equity for 2021 was -84.6 %, a 22.5% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -2.85K -3.48K -553% Apr 1, 2024 Jun 30, 2024
Q1 2024 -130 +7.14K +98.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 336 +781 Oct 1, 2023 Dec 31, 2023
Q3 2023 694 +908 Jul 1, 2023 Sep 30, 2023
Q2 2023 628 +753 Apr 1, 2023 Jun 30, 2023
Q1 2023 -7.27K -7.17K -7652% Jan 1, 2023 Mar 31, 2023
Q4 2022 -445 -361 -426% Oct 1, 2022 Dec 31, 2022
Q3 2022 -215 -147 -217% Jul 1, 2022 Sep 30, 2022
Q2 2022 -124 -56.8 -84% Apr 1, 2022 Jun 30, 2022
Q1 2022 -93.7 -31 -49.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 -84.6 -15.5 -22.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 -67.8 +16.5 +19.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -67.6 +11.2 +14.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 -62.7 +45.2 +41.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 -69.1 +12.6 +15.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -84.3 -16.9 -25% Jul 1, 2020 Sep 30, 2020
Q2 2020 -78.9 -13.3 -20.3% Apr 1, 2020 Jun 30, 2020
Q1 2020 -108 -58.3 -117% Jan 1, 2020 Mar 31, 2020
Q4 2019 -81.7 -39.9 -95.5% Oct 1, 2019 Dec 31, 2019
Q3 2019 -67.5 -30.8 -83.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 -65.6 -24.7 -60.5% Apr 1, 2019 Jun 30, 2019
Q1 2019 -49.6 -5.61 -12.7% Jan 1, 2019 Mar 31, 2019
Q4 2018 -41.8 +16.8 +28.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 -36.7 +57.8 +61.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -40.9 +38.8 +48.7% Apr 1, 2018 Jun 30, 2018
Q1 2018 -44 +39 +47% Jan 1, 2018 Mar 31, 2018
Q4 2017 -58.5 +29.4 +33.4% Oct 1, 2017 Dec 31, 2017
Q3 2017 -94.5 -4.02 -4.44% Jul 1, 2017 Sep 30, 2017
Q2 2017 -79.7 +32.2 +28.8% Apr 1, 2017 Jun 30, 2017
Q1 2017 -83 +89 +51.7% Jan 1, 2017 Mar 31, 2017
Q4 2016 -87.9 -12.7 -16.9% Oct 1, 2016 Dec 31, 2016
Q3 2016 -90.5 -233 -164% Jul 1, 2016 Sep 30, 2016
Q2 2016 -112 +935 +89.3% Apr 1, 2016 Jun 30, 2016
Q1 2016 -172 -97.8 -132% Jan 1, 2016 Mar 31, 2016
Q4 2015 -75.2 -150 -200% Oct 1, 2015 Dec 31, 2015
Q3 2015 142 +70.5 +98.2% Jul 1, 2015 Sep 30, 2015
Q2 2015 -1.05K -1.17K -930% Apr 1, 2015 Jun 30, 2015
Q1 2015 -74.1 +15.3 +17.1% Jan 1, 2015 Mar 31, 2015
Q4 2014 75 +118 Oct 1, 2014 Dec 31, 2014
Q3 2014 71.7 -40.6 -36.2% Jul 1, 2014 Sep 30, 2014
Q2 2014 126 +0.21 +0.17% Apr 1, 2014 Jun 30, 2014
Q1 2014 -89.4 -538 -120% Jan 1, 2014 Mar 31, 2014
Q4 2013 -43.2 +2.09K +98% Oct 1, 2013 Dec 31, 2013
Q3 2013 112 -222 -66.4% Jul 1, 2013 Sep 30, 2013
Q2 2013 126 -1.04K -89.2% Apr 1, 2013 Jun 30, 2013
Q1 2013 448 +1.03K Jan 1, 2013 Mar 31, 2013
Q4 2012 -2.14K -1.74K -442% Oct 1, 2012 Dec 31, 2012
Q3 2012 335 Jul 1, 2012 Sep 30, 2012
Q2 2012 1.17K Apr 1, 2012 Jun 30, 2012
Q1 2012 -581 Jan 1, 2012 Mar 31, 2012
Q4 2011 -394 Oct 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.